Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Public ClinicalTrials.gov record NCT01857323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Study identification
- NCT ID
- NCT01857323
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 317 participants
Conditions and interventions
Interventions
- Albuterol Spiromax® Drug
Drug
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2013
- Primary completion
- Jul 31, 2013
- Completion
- Aug 31, 2013
- Last update posted
- Jun 7, 2015
2013
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 10620 | Phoenix | Arizona | — | — |
| Teva Investigational Site 10637 | Costa Mesa | California | — | — |
| Teva Investigational Site 10635 | Huntington Beach | California | — | — |
| Teva Investigational Site 10647 | Rolling Hills Estates | California | — | — |
| Teva Investigational Site 10643 | San Diego | California | — | — |
| Teva Investigational Site 10644 | San Jose | California | — | — |
| Teva Investigational Site 10622 | Centennial | Colorado | — | — |
| Teva Investigational Site 10634 | Denver | Colorado | — | — |
| Teva Investigational Site 10645 | Wheat Ridge | Colorado | — | — |
| Teva Investigational Site 10633 | Miami | Florida | — | — |
| Teva Investigational Site 10640 | Ormond Beach | Florida | — | — |
| Teva Investigational Site 10641 | Overland Park | Kansas | — | — |
| Teva Investigational Site 10636 | Bethesda | Maryland | — | — |
| Teva Investigational Site 10631 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 10646 | Plymouth | Minnesota | — | — |
| Teva Investigational Site 10627 | St Louis | Missouri | — | — |
| Teva Investigational Site 10642 | Bozeman | Montana | — | — |
| Teva Investigational Site 10613 | High Point | North Carolina | — | — |
| Teva Investigational Site 10616 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 10618 | Canton | Ohio | — | — |
| Teva Investigational Site 10615 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 10624 | Tulsa | Oklahoma | — | — |
| Teva Investigational Site 10625 | Eugene | Oregon | — | — |
| Teva Investigational Site 10626 | Medford | Oregon | — | — |
| Teva Investigational Site 10632 | Portland | Oregon | — | — |
| Teva Investigational Site 10639 | Charleston | South Carolina | — | — |
| Teva Investigational Site 10617 | Spartanburg | South Carolina | — | — |
| Teva Investigational Site 10630 | Dallas | Texas | — | — |
| Teva Investigational Site 10623 | New Braunfels | Texas | — | — |
| Teva Investigational Site 10638 | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01857323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01857323 live on ClinicalTrials.gov.